-
Product Insights
NewSarcopenia – Drugs In Development, 2024
Empower your strategies with our Sarcopenia – Drugs In Development, 2024 report and make more profitable business decisions. Sarcopenia is an aging-associated condition which is characterized by loss of muscle mass, strength, and function. Symptoms include weakness, loss of endurance, and poor balance. Causes of sarcopenia include a loss of nerve cells, low hormone levels, and a decline in the body’s ability to convert protein to energy. Treatment includes hormone replacement therapy (HRT), exercise, and dietary supplements. The Sarcopenia drugs in...
-
Sector Analysis
Asia Hydrogen Market Size and Analysis by Application Areas, Upcoming Projects, Policies and Key Players to 2030
Asia Hydrogen Market Report Overview The current Asian active hydrogen capacity is at 0.11 mtpa. Asia aims to develop a clear strategy for how to promote hydrogen use in the transportation, power, and other hard-to-abate sectors such as iron and steel industries. The use of renewable hydrogen is seen as a key lever for the decarbonization of hard-to-decarbonize sectors. The following are some of the key highlights of the Asia hydrogen market: Asia is positioned as one of the major...
-
Product Insights
Drug Eluting Stents (DES) Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Drug Eluting Stents (DES) Pipeline Market Report Overview Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The Drug Eluting Stents (DES) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key...
-
Product Insights
Peripheral Vascular Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Peripheral Vascular Devices Pipeline Market Report Overview Peripheral vascular devices are used to treat peripheral vascular disease (PVD). The Peripheral Vascular Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments · Peripheral Vascular Stents · ...
-
Company Insights
Shiseido Company, Limited – Company Overview and Analysis, 2023 Update
Shiseido Company Overview Shiseido develops, produces, and distributes cosmetics, health, and beauty care products. The company produces products for skincare, shampoo and haircare, body care, fragrances, and styling products among others. Shiseido markets its products under the Shiseido, Cle de Peau Beaute, NARS, Issey Miyake, Narciso Rodriguez, Elixir, Anessa, Senka, and Baum, among other brands. The company operates subsidiaries, factories, and production sites in Japan, the Americas, the Middle East and Africa, Europe and Asia-Pacific. The Shiseido company analysis report...
-
Company Profile
Shiseido Co Ltd – Company Profile
Shiseido Co Ltd (Shiseido) develops, produces and distributes cosmetics, health and beauty care products. The company’s product portfolio includes skincare products, shampoo and hair care products, body care products, fragrances, styling products, hair color products, perm products and cosmetics. The company markets its products under Shiseido, Cle de Peau Beaute, Nars, Issey Miyake, narciso rodriguez, Elixir, Anessa, Senka, Baum and Shiseido Professional brand names. Shiseido sells these products through department and cosmetic stores, perfumeries, drug stores and mass merchandising stores....
Add to Basket -
Product Insights
Coronary Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Coronary Stents Pipeline Market Report Overview A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents. Coronary stent...
-
Product Insights
Drug Eluting Stents, Elixir Medical Corporation, DESyne, pricing in the Taiwan, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Drug Eluting Stents, Elixir Medical Corporation, DESyne, pricing in the Taiwan, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices...
-
Sector Analysis
Low-Carbon Hydrogen Market Size, Trends, Country Analysis, Production Process, Cost by Technology, Key Players and Forecast to 2030
Accessing the in-depth insight from the ‘Low-Carbon Hydrogen Market’ report can help you: Facilitate decision-making by providing trend analysis in the low-carbon hydrogen market. Develop business strategies by understanding the drivers and challenges of the market. Position yourself to gain the maximum advantage of the industry’s growth potential. Maximize potential in the growth of the low-carbon hydrogen market Identify key partners, geographies, and business-development avenues. Analyze the key end-users, market size, growth, demand, as well as the cost of production...
-
Company Profile
Majesco – Company Profile
Majesco, a subsidiary of Thoma Bravo LLC, provides cloud insurance software solutions for insurance business transformation. Its offerings include core insurance solutions for property, general insurance and life insurance, annuities, pension and group/ voluntary benefits. Its proprietary solutions and trademarks include Majesco, Agile Technologies, Majesco CloudInsurer, Majesco Digital1st, Digital1st, Advice Plus, Illustrate Plus, Channel Plus, MajescoMastek, Elixir, Cover-All, and Admin Plus. It has presence across the US, the UK, Mexico, Ireland, Canada, Singapore, Malaysia, Thailand, and India. Majesco is headquartered...
Add to Basket